The DOI matches its Crossref record; 182 of the 184 references it cites were found in a registry or an index.
The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Abstract
The JAK/STAT signaling pathway is an universally expressed intracellular signal transduction pathway and involved in many crucial biological processes, including cell proliferation, differentiation, apoptosis, and immune regulation. It provides a direct mechanism for extracellular factors-regulated gene expression. Current researches on this pathway have been focusing on the inflammatory and neoplastic diseases and related drug. The mechanism of JAK/STAT signaling is relatively simple. However, the biological consequences of the pathway are complicated due to its crosstalk with other signaling pathways. In addition, there is increasing evidence indicates that the persistent activation of JAK/STAT signaling pathway is closely related to many immune and inflammatory diseases, yet the specific mechanism remains unclear. Therefore, it is necessary to study the detailed mechanisms of JAK/STAT signaling in disease formation to provide critical reference for clinical treatments of the diseases. In this review, we focus on the structure of JAKs and STATs, the JAK/STAT signaling pathway and its negative regulators, the associated diseases, and the JAK inhibitors for the clinical therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A member of its family, the JAK2/STAT3 signal pathway, is involved in neuronal death and nervous reorganization in ischemic encephalopathy [62].”
Citations
Cites
1 retracted
Ling, L., Zhang, S., Zhi, L.-D., Li, H., Wen, Q.-K., Li, G., & Zhang, W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.042 · Cited by 31
RetractedSTATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Scott, D. L., Wolfe, F., & Huizinga, T. W. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,263
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1594 · Cited by 2,490
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
Epidemiology of Parkinson’s disease
Tysnes, O., & Storstein, A. M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1686-y · Cited by 2,437
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Flagged first, then by citations
2 of the 184 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Seif, 2017, The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells, Cell Commun. Sign., 15, 1
- Oshea, 2015, The JAK-STAT pathway: impact on human disease and therapeutic intervention*, Annu. Rev. Med., 66, 311, 10.1146/annurev-med-051113-024537 · DOI
- Yan, 2018, Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases, Clin. Immunol., 189, 4, 10.1016/j.clim.2016.09.014 · DOI · Paper page
Cited by
Sorted by citations
Items 701–800 of 1,000
Guo, M., Zhang, L., Wang, H., Zhou, Q., Zhu, X., Fu, X., Yang, J., Liu, S., Guo, D., & Zhang, B. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45070353 · Cited by 2
Self-citationYin, Z., You, B., Bai, Y., Zhao, Y., Liao, S., Sun, Y., & Wu, Y. (2023) · Advanced Biology · doi:10.1002/adbi.202300025 · Cited by 2
Liu, X., Wang, N., Yu, H., Zhang, X., Cao, M., & Li, C. (2024) · Comparative Immunology Reports · doi:10.1016/j.cirep.2023.200124 · Cited by 2
Wang, X., Li, J., Nong, J., Deng, X., Chen, Y., Wu, P., & Huang, X. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10684-x · Cited by 2
Wang, Z., Jin, X., Zeng, J., Xiong, Z., & Chen, X. (2024) · Annals of Hematology · doi:10.1007/s00277-024-05703-1 · Cited by 2
Ma, J., Cui, J., Qu, Y., Chen, J., Zhao, Y., Han, Y., Liu, Y., Huang, B., & Wang, X. (2024) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2024.109560 · Cited by 2
The role of interleukin-20 in liver disease: Functions, mechanisms and clinical applications
Wang, K., Zhan, H.-Q., Hu, Y., Yuan, Z.-Y., Yang, J., Yang, D., Tao, L.-S., & Xu, T. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29853 · Cited by 4
Li, W., Wang, Y., Li, X., Wu, H., & Jia, L. (2024) · Oncology Letters · doi:10.3892/ol.2024.14406 · Cited by 2
Self-citationXu, D.-M., Chen, L.-X., Zhuang, X.-Y., Han, H., & Mo, M. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.95490 · Cited by 2
Phan, T.-C.-L., Chiang, Y.-S., Su, M., Liang, Y.-J., & Juang, S.-J. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060339 · Cited by 2
Maqsood, M., Saeed, R. A., Khan, M. I., Faisal, M. N., Saeed, H. A., Abdi, G., & Aadil, R. M. (2024) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2024.101378 · Cited by 2
Design, synthesis and activity screening of cedrol derivatives as small molecule JAK3 inhibitors
Ma, B., Li, H., Huang, Y., Guo, Y., Xu, C., & Li, W. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107762 · Cited by 2
Falah, G., Sharvit, L. E., & Atzmon, G. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112586 · Cited by 2
Jian, L., Liu, X., Xie, Y., Wu, M., Mao, W., & Ying, X. (2024) · PeerJ · doi:10.7717/peerj.18324 · Cited by 2
Meng, T., He, J., Huo, Q., Wang, Y., Ren, Q., & Kang, Y. J. (2024) · Journal of Applied Toxicology · doi:10.1002/jat.4724 · Cited by 2
Self-citationSetiwalidi, K., Li, Y., Ma, Y., Hao, Z., Zhao, Y., Zhang, Y., Liang, X., Tian, T., Ruan, Z., Yao, Y., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1431908 · Cited by 2
Alzahrani, K. J., Safadi, M. E., Alsharif, K. F., Alzahrani, F. M., & Hayat, M. F. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.102730 · Cited by 2
Role of Aging in Ulcerative Colitis Pathogenesis: A Focus on ETS1 as a Promising Biomarker
Ni, M., Peng, W., Wang, X., & Li, J. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s504040 · Cited by 2
Li, L., Lyu, H., Chen, Q., Bai, Y., Yu, J., & Cai, R. (2025) · Journal of Breast Cancer · doi:10.4048/jbc.2024.0177 · Cited by 2
Lai, J., Guan, Y., Li, J., Zeng, Y., Zeng, F., Zhu, B., & Li, Y. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.06.041 · Cited by 2
Small molecular inhibitors targeting Janus kinases (JAKs) for the treatment of psoriasis
Zhang, D., Miao, X., Liu, P., Liu, H., Li, C., Liu, Y., & Sun, Y. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117904 · Cited by 2
Liang, J., Liu, J., Sun, W., Li, P., Sun, H., Cao, W., Dai, Y., Xu, T., & Yu, P. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402936 · Cited by 2
Deng, K., Jiang, H., Xie, S., Yin, M., Guo, C., Huang, L., Ma, J., Kuang, Y., Xiang, Y., & Guo, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1629886 · Cited by 2
Xu, H., Shen, K., Jiang, B., Xu, Q., Li, B., Ke, Z., Cheng, Q., Zhu, S., Wang, D., Song, Y., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06818-3 · Cited by 2
Li, Y., Zhang, W., Zhao, Y., Zhu, T., & Li, Q. (2021) · Journal of Proteomics · doi:10.1016/j.jprot.2021.104123 · Cited by 2
A General Overview of Epilepsy: its Classification, and Management
Yavuz, Y., & Sidow, N. O. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub128.c584 · Cited by 3
Sartori, R., Ahrens, K. P., Wilkes, R., & Marsella, R. (2023) · Veterinary Sciences · doi:10.3390/vetsci10080512 · Cited by 2
Lou, F., Zhang, Y., Xu, A., & Gao, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1272393 · Cited by 2
Cheng Luo1, Y. Y. (2023) · International Journal of Frontiers in Medicine · doi:10.25236/ijfm.2023.051014 · Cited by 2
Statistical and Clustering Analysis of Safety Profiles of FDA-Approved Protein Kinase Inhibitors
Radulian, I. L., Nițulescu, G., Zanfirescu, A., & Nițulescu, G. M. (2024) · Applied Sciences · doi:10.3390/app142411757 · Cited by 2
Combination of PRL-3 Inhibitor with Sorafenib Synergistically Promotes AML ApoptosisPreprint
Chen, X., Rong, D., Cai, W., Tong, X., & Wang, H. (2021) · Research Square · doi:10.21203/rs.3.rs-191026/v1 · Cited by 2
Yasmin, S., Yadav, A. K., Michael, R. H., Khatun, S., Chauhan, S., Kurmi, M. K., Kaur, S., Haider, N., Sah, A. K., Kumar, A. S., et al. (2023) · Preprints.org · doi:10.20944/preprints202308.1553.v1 · Cited by 2
Hussain, S. (2024) · Student s Journal of Health Research Africa · doi:10.51168/sjhrafrica.v5i3.1067 · Cited by 1
The Gut-Liver Axis in NAFLD Progression: Insights into Pathogenesis and Therapeutic Opportunities
Dubey, K., & Singh, R. (2024) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-18773 · Cited by 1
Márquez-Pedroza, J., Hernández-Preciado, M. R., Valdivia-Tangarife, E. R., Padilla, F. J. A., Mireles-Ramírez, M. A., & Torres-Mendoza, B. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126741 · Cited by 1
Occupational exposure to arsenic and leukopenia risk: Toxicological alert
Bidu, N. S., Lemos, D. S., & Fernandes, B. J. D. (2024) · Toxicology and Industrial Health · doi:10.1177/07482337241277261 · Cited by 1
Recombinant leptins affect lipid metabolism in hepatocytes of Cynoglossus semilaevis
Cai, X., Li, Y., Meng, Z., Cui, A., Jiang, Y., & Xu, Y. (2024) · Aquaculture Reports · doi:10.1016/j.aqrep.2024.102423 · Cited by 1
Majumdar, A., Saraf, S. K., & Rao, S. P. (2024) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2024.100129 · Cited by 1
STAT3-related lncRNAs in colorectal cancer progression; Special focus on immune cell’s evasion
Saadh, M. J., Hamid, J. A., Malathi, H., Kazmi, S. W., Ahmed, M. H., Sharma, A., Kumar, M. R., & Husseen, B. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.155810 · Cited by 1
A Comprehensive Pharmacological Review of Natural Products Active Ingredients in Ulcerative Colitis
Hong, R., Zhang, Z., Sun, X., Chen, Y., Wei, H., Chen, Q., Zhou, L., Zhou, X., Chen, W., & Wan, J. (2025) · The Natural Products Journal · doi:10.2174/0122103155348415241119073736 · Cited by 1
Self-citationThe role of the JAK2-mediated inflammatory pathway in ischemic stroke
Guo, Z., Liu, K. J., & Qi, Z. (2025) · Brain Network Disorders · doi:10.1016/j.bnd.2024.09.001 · Cited by 1
Arribas‐Rodríguez, E., Prado, Á. D., Andrés-Asenjo, B. D., Velayos, B., Barrio, J., Romero, A., García-Alonso, F. J., Martín‐Muñoz, Á., Garrote, J. A., Arranz, E. M., et al. (2025) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2025.100271 · Cited by 1
Xu, H., Tang, X., Li, P.-F., Zhang, D., Ta, G., Lü, J., & Wang, J. (2025) · Journal of Visualized Experiments · doi:10.3791/67728 · Cited by 1
Epsin3 promotes non-small cell lung cancer progression via modulating EGFR stability
Su, H., Shen, J., Gao, C., Zhao, Y., Deng, W., Qin, B., Zhang, X., Lai, J., Wang, Q., Dou, J., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01358-1 · Cited by 1
Silva, D. D. O., Lima, M. A., de Freitas, T. M., Ferreira, F. C. S., de Freitas, A. K. L., Mota, M. R. L., da Silva, J. A., Clementino, M., & Havt, A. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03922-5 · Cited by 1
Du, Y., Ai, M., Miao, J., Yan, S., Liu, H., Wang, Y., Zhao, J., & Zhang, K. (2025) · Research in Veterinary Science · doi:10.1016/j.rvsc.2025.105631 · Cited by 1
Self-citation林, 维. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541163 · Cited by 1
Lu, Q., Tian, W., Cheng, Y., Chen, Z., Cao, Y., Zhao, H., Zhou, T., Chang, Y., & Zhou, Y. (2025) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.14270 · Cited by 1
Jin, Y., Shama, A., Tang, H., Zhao, T. S., Zhang, X., Yang, F., & Chen, D. (2025) · Metabolites · doi:10.3390/metabo15050326 · Cited by 1
Fischer, F., Temml, V., & Schuster, D. (2025) · Molecules · doi:10.3390/molecules30102183 · Cited by 1
Pornsupawat, J., & Gleeson, M. P. (2025) · Biomedical Engineering International Conference · doi:10.1109/bmeicon66226.2025.11113731 · Cited by 1
Jin, Y., Lahcen, M. A., Gong, T., Fang, H., Yue, Y., Ma, Y., Adardour, M., Cheng, Z., Xu, N., Baouid, A., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178069 · Cited by 1
Peng, X., Wang, Y., Chen, Y., Hu, Y., Wu, F., Zhang, P., Xu, W., & Wei, Y. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s530776 · Cited by 1
Self-citationda Cunha, L. S., Farias, I. M., Nogueira, B. M. D., Machado, C. B., Pessoa, F. M. C. D. P., Oliveira, D. D. S., de Morais, G. P., Thé, A. P., Thé, P. M. P., de Moraes, M. O., et al. (2025) · International Journal of Translational Medicine · doi:10.3390/ijtm5030043 · Cited by 1
Successful Treatment of Pigmented Purpuric Dermatoses With Abrocitinib: A Case Report
Zhang, Y., Lu, X.-J., & Chen, L. (2026) · Clinical Case Reports · doi:10.1002/ccr3.72463 · Cited by 1
Han, H., Li, Y., Wang, L., Jin, Z., Zhou, W., Zhang, B., Jia, C., Zhang, W., Wang, Y., Li, Q., et al. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70235 · Cited by 1
Self-citationHou, Y., Li, Q., Li, H., He, J., & Li, C. (2025) · Reviews in Aquaculture · doi:10.1111/raq.70101 · Cited by 2
Shi, H.-X., Gao, Y., & Wang, S.-R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1644394 · Cited by 1
Fu, J., Huang, T., Zhou, J., Hu, G., & Tu, L. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.116114 · Cited by 1
Pharmacological Inhibition of JAK/STAT-IL2 Axis Alleviated Cisplatin-Induced Ototoxicity
Zheng, S., Liu, C., Li, J., Yu, H., Qiu, S., Li, W., Zhao, L., Zeng, X., Chen, B., & He, Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05350-1 · Cited by 1
Cancer Stem Cells in Human Gastrointestinal and Hepatic Cancers
Bu, J., Cui, M., Zhang, Y., Yu, L., Zhu, X., Peng, F., & Zhang, H. (2025) · MedComm · doi:10.1002/mco2.70513 · Cited by 1
Epigenetic Mechanisms, Assessment and Therapeutics of Epidermal Stem Cells in Skin Aging
Yang, J., Xu, M., Duan, Y., Yuan, Y., Zhang, J., & Jiang, W. (2025) · Stem Cells International · doi:10.1155/sci/7575250 · Cited by 2
Chronic nonbacterial osteomyelitis: a typical case and review
Li, Q., Wang, Y. T., Fei, L., & Zheng, P. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1747342 · Cited by 1
Self-citationJAK-STAT signaling: molecular mechanism and targeted treatment in dento-maxillofacial abnormalities
Huang, Z., Cui, Y., Zhang, W., Shen, J., Dai, Q., Sun, S., & Jiang, L. (2026) · International Journal of Oral Science · doi:10.1038/s41368-025-00399-z · Cited by 1
Self-citationTang, B., Fang, N., Wang, T., Meng, X., & Su, J. (2026) · Phytotherapy Research · doi:10.1002/ptr.70266 · Cited by 1
Wu, J. Q., Hu, C., & Yang, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1776431 · Cited by 1
Colacurci, D., Pellegrino, R., Lamart, A., Staiano, D., Costanzo, I. D., Izzo, M., Imperio, G., Landa, F., Scamardella, G., Lella, E. D., et al. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48040421 · Cited by 1
Enteropathy in STAT3 GOF syndrome: Insights into the role of the JAK-STAT pathway
Caranfil, C., Crepaldi, M., Marzollo, A., Vogel, T. P., Schümann, M., Palo, M., Bertin, L., Savarino, E. V., Pizzi, M., Tos, A. P. D., et al. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104086 · Cited by 1
Abdellaoui, S., Tabaa, O. A., Hilliquin, S., d’Alessandro, R., Hecquet, S., Thomas, M., Carvès, S., Combier, A., Allanore, Y., & Avouac, J. (2026) · Clinical Rheumatology · doi:10.1007/s10067-026-08175-y · Cited by 1
Li, X., Yan, M., Cao, A., Zhao, C., Sun, Y., Ziyi, S., Xue, Y., Lei, Y., & Liu, C. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117094 · Cited by 1
Yang, H., Su, B.-W., Bao, Y.-N., Wang, W.-H., Lao, J.-Y., Ji, H.-Y., Han, S., Cui, X.-H., Ren, H.-W., & Luan, Z.-L. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1880374 · Cited by 1
Vahabi, S. M., Heidari, S., Farahmand, Y., Pourgholi, E., Kianfar, N., Memari, H., Tarki, F. E., Bahramian, S., Etesami, I., & Ansari, M. S. (2026) · Dermatology Research and Practice · doi:10.1155/drp/7086209 · Cited by 1
Xing, X., Liu, H., Pang, Y., & Li, S. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108850 · Cited by 1
Hücre İçi Sinyal Yolaklarını Hedefleyen Kemoterapötik Ajanlar
Mutluay, S. U., & Kozacı, L. D. (2021) · Black Sea Journal of Health Science · doi:10.19127/bshealthscience.825971 · Cited by 1
Artamonova, O. G., Karamova, A. Е., Nikonorov, A. А., Анатольевич, В. Д., Vasileva, E. L., & Kubanov, A. A. (2021) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-021-05196-2 · Cited by 1
[Recent research on tofacitinib in the treatment of pediatric rheumatic diseases].
Zhou, S.-H., Xiong, Y.-Q., & Chen, Y. (2022) · PubMed Central · doi:10.7499/j.issn.1008-8830.2201081 · Cited by 1
Zhou, W. J., Ma, X., Jia, X., Zheng, J., Yan, L., & Fu, Y. (2022) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14466 · Cited by 1
Comprehensive analysis of STAT family members as prognostic markers in human breast cancer
(2022) · European Journal of Gynaecological Oncology · doi:10.22514/ejgo.2022.043 · Cited by 1
Xihong, Y. E., Wu, Y., Qinyi, C. H. E. N., Hua, S. O. N. G., & CHENG, J. (2023) · Food Science and Technology · doi:10.1590/fst.122322 · Cited by 1
Dąbala, M., Świder, M., Kasela, T., Buda, P., & Grabarek, B. O. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666230407122254 · Cited by 1
[Research progress on the effect of iron oxide nanoparticles in macrophage polarization].
Zhang, H., Zhang, X., Feng, Y., Du, C., Wang, Y., & Guo, X. (2023) · PubMed Central · doi:10.7507/1001-5515.202209027 · Cited by 1
Self-citationWang, Y., Qi, H., Wang, T., Zhang, W., Shi, X., Zhan, Q., Li, Q., & Zhong, M. (2023) · Journal of Chemotherapy · doi:10.1080/1120009x.2023.2203610 · Cited by 1
Self-citationCurrent Researches in Health Sciences-II
Guliyev, E., Elasan, S., Ateş, Y., Güner, T. A., Yavuz, Y., Gencan, G., Sidow, N. O., Türk, S., Selçuk, E., Çetinkaya, B. D., et al. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub128 · Cited by 1
Türk, S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub128.c626 · Cited by 1
Successful treatment of rheumatoid neutrophilic panniculitis with tofacitinib
de Almeida, H. L., Furtado, V. D., Issaacson, V. S., & Boff, A. L. (2024) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abd.2023.05.010 · Cited by 1
Progress of Chinese Medicine in Regulating JAK/STAT Signaling Pathway Mediating Ulcerative Colitis
代, 月. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1451545 · Cited by 1
Khan, K., Zahid, M., Ali, N., Attaullah, S., Ullah, M., Khan, K., Muhammad, I., Abusharha, A., Aschner, M., & Khan, H. Z. (2024) · Gene Reports · doi:10.1016/j.genrep.2024.101950 · Cited by 1
Tofacitinib in the treatment of ulceral colitis: real-world clinical practice and prospects
Трухан, Д. И. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-344 · Cited by 1
He, J., Geng, Z., Chen, M., Ren, X., Zhu, P., Liu, Z., Zhou, J., Chen, H., Xiao, C., & Li, X. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117544 · Cited by 1
García-Bravo, L., Villegas, Á., Uceda, B. L., Mariscal, A., Vadillo, C., Barbero, M. A. N., Hermosa, J. L. R., Valeros, B. M., Plaza-Hernández, J. C., Fernández‐Arquero, M., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41311 · Cited by 1
Recent Prospectives of Cellular Signaling Role for Mammary Gland Carcinogenesis
Kashyap, M. K., Roy, S., Jaiswal, S., Verma, S., Srivastava, S., Nigam, A. K., Kumar, A., Singh, B., Tiwari, V. P., Mahima, M., et al. (2025) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206319933241104100736 · Cited by 1
Zhang, Z., Yang, T., Xie, H., Jiang, M., Li, Y., & Liang, C. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128342405241204055321 · Cited by 1
Acne due to JAK inhibitors in inflammatory bowel disease
Awad, A., Christensen, B., Segal, J. P., & Ross, G. (2024) · Frontline Gastroenterology · doi:10.1136/flgastro-2024-102841 · Cited by 1
Ali, G. F., Hassanein, E. H. M., Abdel‐Reheim, M. A., Arafa, E. A., & Mohamed, W. R. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70339 · Cited by 2
Sarwar, M., Irfan, H. M., Alamgeer, Jabbar, Z., Asim, M. H., Hassan, M. S., & Nawaz, S. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11305-4 · Cited by 1
Zhang, Y., Meng, X., & Li, M. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2542530 · Cited by 1
Wu, H., Jin, X., & Zhang, H. (2025) · BMC Ophthalmology · doi:10.1186/s12886-025-04403-2 · Cited by 1
Yiyi Song1, X. L. (2022) · Frontiers in Medical Science Research · doi:10.25236/fmsr.2022.040606 · Cited by 1
Mohammad, T. A. M. (2023) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14643 · Cited by 1
Tsujii, A., Isoda, K., Yoshimura, M., Nakabayashi, A., Kim, D., Tamada, T., Yamamoto, K., & Ohshima, S. (2022) · Research Square · doi:10.21203/rs.3.rs-2110699/v1 · Cited by 1
Metadata
- Authors
- Xin, P., Xu, X., Deng, C., Liu, S., Wang, Y., Zhou, X., Ma, H., Wei, D., & Sun, S.
- Affiliations
- Harbin Medical University (CN)
- China Pharmaceutical University (CN)
- Southeast University (CN)
- Corresponding author
- Sun, Shiqin
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 80
- Pages
- 106210
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W3001733563
- Cited by
- 1,010
- References
- 184
- Citations by year
- 2026: 125 · 2025: 229 · 2024: 224 · 2023: 195 · 2022: 160 · 2021: 56 · 2020: 20
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- International Immunopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundamental Research Funds for the Central Universities (2018XN-25, JFWLD201904)
- National Natural Science Foundation of China (81903763)
- China Postdoctoral Science Foundation (2019M661312)
- Natural Science Foundation of Heilongjiang Province (YQ2019H005)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- JAK/STAT signaling, JAK inhibitors, STAT proteins, JAK kinases, inflammatory diseases, cancer, immune regulation, signaling crosstalk, cell proliferation and differentiation, apoptosis
- MeSH terms
- Animals, Disease Models, Animal, Humans, Immune System Diseases, Inflammation, Signal Transduction, Cytokines, Protein Kinase Inhibitors, STAT Transcription Factors, Janus Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review